학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 66건 | 목록 1~20
Academic Journal
Sanmamed MF; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Medical Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IDISNA) , Pamplona, Spain.; de Andrea CE; Instituto de Investigación Sanitaria de Navarra (IDISNA) , Pamplona, Spain.; Department of Pathology, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Ruiz-Guillamon D; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Rodriguez-Ruiz ME; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Medical Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Radiotherapy Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Ortego I; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Eguren-Santamaría I; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Medical Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IDISNA) , Pamplona, Spain.; Benito A; Radiology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Lopez-Janeiro A; Department of Pathology, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Gonzalez Gomariz J; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Villalba-Esparza M; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut.; Molina A; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Krasko A; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Ponz-Sarvise M; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Medical Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Ciberonc, Madrid, Spain.; Lopez-Picazo JM; Medical Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Gomis G; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Molero-Glez P; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Alexandru R; Department of Pathology, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Pérez-Domínguez P; Department of Pathology, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Rodriguez I; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IDISNA) , Pamplona, Spain.; Sanchez-Gregorio S; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Perez-Gracia JL; Medical Oncology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Melero I; Program in Solid Tumors, Centro de Investigación Médica Aplicada (CIMA), Pamplona, Spain.; Instituto de Investigación Sanitaria de Navarra (IDISNA) , Pamplona, Spain.; Ciberonc, Madrid, Spain.; Immunology Department, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Eguren-Santamaria I; Immunology and Immunotherapy, Clinica Universidad de Navarra Centro de Investigacion Medica Aplicada, Pamplona, Navarre, Spain.; Department of Oncology, Clinica Universidad de Navarra Cancer Center, Pamplona, Navarre, Spain.; IdiSNA, Pamplona, Navarre, Spain.; Melero I PhD; Immunology and Immunotherapy, Clinica Universidad de Navarra Centro de Investigacion Medica Aplicada, Pamplona, Navarre, Spain msanmamed@unav.es imelero@unav.es.; IdiSNA, Pamplona, Navarre, Spain.; CIBERONC, Madrid, Community of Madrid, Spain.; Immune Regulation and Immune Interactions Group, Centre for Immuno-Oncology, University of Oxford Nuffield Department of Medicine, Oxford, UK.; Rodríguez I; Immunology and Immunotherapy, Clinica Universidad de Navarra Centro de Investigacion Medica Aplicada, Pamplona, Navarre, Spain.; IdiSNA, Pamplona, Navarre, Spain.; Ortego I; Department of Oncology, Clinica Universidad de Navarra Cancer Center, Pamplona, Navarre, Spain.; Armero M; Immune Regulation and Immune Interactions Group, Centre for Immuno-Oncology, University of Oxford Nuffield Department of Medicine, Oxford, UK.; Galvez-Cancino F; Immune Regulation and Immune Interactions Group, Centre for Immuno-Oncology, University of Oxford Nuffield Department of Medicine, Oxford, UK.; López-Janeiro A; Department of Pathology, Clinica Universidad de Navarra Cancer Center, Pamplona, Navarre, Spain.; De Andrea CE; IdiSNA, Pamplona, Navarre, Spain.; CIBERONC, Madrid, Community of Madrid, Spain.; Department of Pathology, Clinica Universidad de Navarra Cancer Center, Pamplona, Navarre, Spain.; F Sanmamed M; Immunology and Immunotherapy, Clinica Universidad de Navarra Centro de Investigacion Medica Aplicada, Pamplona, Navarre, Spain msanmamed@unav.es imelero@unav.es.; Department of Oncology, Clinica Universidad de Navarra Cancer Center, Pamplona, Navarre, Spain.; IdiSNA, Pamplona, Navarre, Spain.; CIBERONC, Madrid, Community of Madrid, Spain.
Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Academic Journal
Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Cuesta R; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Aranda F; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Martinez-Riaño A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Department of Oncology, Clinica Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Risson A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Melero A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain.; Gomis G; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Department of Oncology, Clinica Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain; Nuffield Department of Medicine (NDM), University of Oxford, Oxford, UK. Electronic address: imelero@unav.es.
Publisher: Cell Press Country of Publication: United States NLM ID: 101665956 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-8025 (Electronic) Linking ISSN: 24058025 NLM ISO Abbreviation: Trends Cancer Subsets: MEDLINE
Academic Journal
Eguren-Santamaría I; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Department of Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Sanmamed MF; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Department of Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Molero-Glez P; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Perez-Gracia JL; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Department of Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Melero I; Combination Strategies for Translational Immunotherapy, Immunology and Immunotherapy Program, Centro de Investigación Médica Aplicada (CIMA) Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Teijeira A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Garasa S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Sanchez-Gregorio S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Gomis G; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Martinez-Monge R; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Radiation Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Pinci B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Valencia K; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Solid Tumors Program, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Barbés B; Department of Radiation Physics and Radiation Protection, Clínica Universidad de Navarra, Pamplona, Spain.; Bolaños E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Azpilikueta A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; García-Cardosa M; Department of Physics and Applied Mathematics, Universidad de Navarra, Pamplona, Spain.; Burguete J; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Physics and Applied Mathematics, Universidad de Navarra, Pamplona, Spain.; Eguren-Santamaría I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Medical Oncology, Universidad de Navarra, Pamplona, Spain.; Garate-Soraluze E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Perez-Gracia JL; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Medical Oncology, Universidad de Navarra, Pamplona, Spain.; de Andrea CE; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Department of Anatomy, Physiology and Pathology, Universidad de Navarra, Pamplona, Spain.; Rodriguez-Ruiz ME; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Olivera I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Luri-Rey C; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Teijeira A; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Gomis G; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Palencia B; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Melero I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Luri-Rey C; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Department of Oncology, Clinica Universidad de Navarra, Madrid, Spain.; Matos I; Department of Oncology, Clinica Universidad de Navarra, Madrid, Spain.; Berraondo P; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Melero I; Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Department of Oncology, Clinica Universidad de Navarra, Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Glez-Vaz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Azpilikueta A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Olivera I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Gomis G; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Álvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pérez-Gracia JL; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Ciordia S; Functional Proteomics Laboratory, CNB-CSIC, Proteored-ISCIII, Madrid, Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Alexandru R; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; de Andrea C; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Teijeira Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Corrales F; Functional Proteomics Laboratory, CNB-CSIC, Proteored-ISCIII, Madrid, Spain.; Zapata JM; Instituto de Investigaciones Biomédicas Alberto Sols (IIBm), CSIC-UAM, Madrid, Spain.; Instituto de Investigación Sanitaria La Paz (IdiPaz), Madrid, Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Departments of Immunology-Immunotherapy, Pathology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE
Academic Journal
Cirella A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Bolaños E; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Luri-Rey C; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Di Trani CA; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Olivera I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Gomis G; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Glez-Vaz J; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Pinci B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Garasa S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Sánchez-Gregorio S; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Azpilikueta A; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Valencia K; Program of Solid Tumors, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Palencia B; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Alvarez M; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Ochoa MC; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Teijeira Á; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Melero I; Program of Immunology and Immunotherapy, Cima Universidad de Navarra, 31008 Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), 31008 Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, 31008 Pamplona, Spain.; Department of Oncology, Clínica Universidad de Navarra, 28027 Madrid, Spain.; Centro Del Cancer de La Universidad de Navarra (CCUN), 31008 Pamplona, Spain.; Nuffield Department of Medicine (NDM), University of Oxford, Oxford OX3 7BN, UK.
Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE
Academic Journal
Olivera I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Bolaños E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Gonzalez-Gomariz J; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Hervas-Stubbs S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Mariño KV; Laboratorio de Glicómica Funcional y Molecular, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad de Buenos Aires 1428, Argentina.; Luri-Rey C; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Etxeberria I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Cirella A; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Egea J; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Glez-Vaz J; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Garasa S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Alvarez M; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Guedan S; Department of Hematology and Oncology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.; Sanmamed MF; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Rabinovich GA; Laboratorio de Glicomedicina, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Ciudad de Buenos Aires 1428, Argentina; Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad de Buenos Aires 1428, Argentina.; Teijeira A; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain.; Melero I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain; Navarra Institute for Health Research (IDISNA), Pamplona, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain. Electronic address: imelero@unav.es.
Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE
Academic Journal
Olivera I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Sanz-Pamplona R; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Oncobell Program, Catalan Institute of Cancer (ICO), Bellvitge Biomedical Research Institute (IDIBELL), CIBERESP, Hospitalet de Llobregat, Barcelona, Spain and ARAID Researcher, Aragon Health Research institute (IIS Aragon), Zaragoza, Spain.; Bolaños E; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Rodriguez I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Etxeberria I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Cirella A; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Egea J; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Garasa S; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Migueliz I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Eguren-Santamaria I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Sanmamed MF; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Glez-Vaz J; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Azpilikueta A; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Alvarez M; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Ochoa MC; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Malacrida B; Center for tumour microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kindgom.; Propper D; Center for tumour microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kindgom.; de Andrea CE; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain.; Berraondo P; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Balkwill FR; Center for tumour microenvironment, Barts Cancer Institute, Queen Mary University of London, London, United Kindgom.; Teijeira Á; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Melero I; Program of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Navarra Institute for Health Research (IDISNA), Pamplona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Report
Aranda F; Immunology and Immunotherapy Research Program, Cima Universidad de Navarra, Pamplona, Navarra, Spain.; Navarra Institute for Health Research (IdiSNA), Recinto del Hospital Universitario de Navarra, Pamplona, Navarra, Spain.; Eguren-Santamaria I; Immunology and Immunotherapy Research Program, Cima Universidad de Navarra, Pamplona, Navarra, Spain.; Navarra Institute for Health Research (IdiSNA), Recinto del Hospital Universitario de Navarra, Pamplona, Navarra, Spain.; Bella Á; Immunology and Immunotherapy Research Program, Cima Universidad de Navarra, Pamplona, Navarra, Spain.; Navarra Institute for Health Research (IdiSNA), Recinto del Hospital Universitario de Navarra, Pamplona, Navarra, Spain.; Berraondo P; Immunology and Immunotherapy Research Program, Cima Universidad de Navarra, Pamplona, Navarra, Spain.; Navarra Institute for Health Research (IdiSNA), Recinto del Hospital Universitario de Navarra, Pamplona, Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Melero I; Immunology and Immunotherapy Research Program, Cima Universidad de Navarra, Pamplona, Navarra, Spain.; Navarra Institute for Health Research (IdiSNA), Recinto del Hospital Universitario de Navarra, Pamplona, Navarra, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Department of Medical Oncology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.; Department of Immunology and Immunotherapy, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Eguren-Santamaria, I.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어